Some cancers are passed down through families, and knowing your genetic risk early can make all the difference. OncoRisk® by 1Cell.Ai is a comprehensive germline test that analyzes 74 genes linked to more than 11 hereditary and familial cancers, including breast, ovarian, colorectal, prostate, and lung cancer. Using next-generation sequencing and AI-powered reporting, it helps identify individuals who carry inherited mutations before cancer even develops.
For oncologists, OncoRisk® provides clinically actionable insights to guide personalized screening plans, preventive surgeries, and treatment decisions. For patients and their families, it offers clarity, allowing them to understand their inherited risk and take proactive steps toward their health. The test also supports cascade testing, meaning at-risk family members can be evaluated using the same findings.
Download the OncoRisk® WhitePaper to explore the science behind the test, the clinical evidence supporting its use, and how it can be integrated into your care journey. Whether you are a clinician or someone concerned about your family history, this whitepaper is your guide to making informed decisions about hereditary cancer risk.